Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Marvelous Marvell Propelling This ETF to Huge Gains

BY | ETF Database
6:06 am ET 06/04/26 | 36 VIEWS
Some stocks are hot. Others are scorching. Having more than tripled over the past year and now flirting with a quadruple over that period, semiconductor maker Marvell Technology (MRVL) is certainly in the scorching camp.It’s obviously benefiting the Direxion Daily MRVL Bull 2X ETF (MRVU), an ETF designed to deliver 200% of the daily performance of the chip stock. MRVU displayed its benefits to short-term traders earlier this week when Marvell surged 32% in a single trading day after Nvidia (NVDA) CEO Jensen Huang overtly complimented the fabless semiconductor company – heady praise to be sure. See more: It’s Nvidia’s World: How Advisors See the Next Phase of AI Perhaps take it with a grain of salt because Nvidia is invested in Marvell, but Huang came right out and said that Marvell could become a $1 trillion company. Such a statement implies an opportunity to occasionally capitalize    with the leveraged MRVU. To get to a market value of $1 trillion, Marvell would need to more than triple from its June 2 market cap. Potentially adding to the allure of Marvell for committed investors and supporting the case for occasional deployment of MRVU is the point that, believe it or not, some market observers don’t view the stock as overvalued. “It is still a 4-star-rated stock that trades at a 13% discount. Technically, as a 4-star-rated stock, we do think that it is attractive compared to its long-term intrinsic valuation on a risk-adjusted basis,” noted Morningstar’s Dave Sekera.More to Come for MRVU?Marvell’s positioning in the data center interconnect (DCI) module space indicates that the chipmaker is a leader in addressing a key artificial intelligence (AI) bottleneck. That is music to bulls’ ears, as well as to traders seeking amplified short-term gains with MRVU. Consider what Chairman and CEO Matt Murphy had to say about DCI modules on Marvell’s latest earnings conference call. “The increase in our revenue outlook continues to be driven by our data center business, which we now expect to grow approximately 50% this fiscal year. Notably, we expect our interconnect business to grow more than 70% [YoY], well above our prior expectation of 50% growth,” he said. Another potential catalyst for the chip stock and thus MRVU, is the stock’s potential inclusion in the S&P 500, which is expected to rebalance on June 19. Still, traders should be careful with MRVU heading into that event. “However, there’s no guarantee Marvell will be added immediately. The selection committee at S&P Dow Jones Indices has discretion when determining which eligible companies to add to the index and sometimes chooses not to make changes at the scheduled time,” noted Barron’s. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

More Commentary

ETF of the Week: NEOS Enhanced Income 1-3 Month T-Bill ETF (CSHI)
BY | ETF Database
10:06 am ET 06/04/26 | 14 VIEWS
SPDR Sector ETFs: Tech Leads May Rally
BY | ETF Database
7:22 am ET 06/04/26 | 26 VIEWS
Vanguard Expands Fixed Income Lineup With New High Yield ETF
BY | ETF Database
10:37 am ET 06/04/26 | 18 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.